Viking Therapeutics Inc [VKTX] stock prices are up 1.44% to $23.94 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The VKTX shares have gain 11.25% over the last week, with a monthly amount drifted -20.39%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Viking Therapeutics Inc [NASDAQ: VKTX] stock has seen the most recent analyst activity on April 08, 2025, when Goldman initiated its Neutral rating and assigned the stock a price target of $30. Previously, Scotiabank started tracking the stock with Sector Outperform rating on February 13, 2025, and set its price target to $102. On February 07, 2025, Citigroup initiated with a Neutral rating and assigned a price target of $38 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating. B. Riley Securities initiated its recommendation with a Buy and recommended $109 as its price target on November 22, 2024. H.C. Wainwright reiterated a Buy rating for this stock on November 04, 2024, and upped its price target to $102. In a note dated September 11, 2024, JP Morgan initiated an Overweight rating and provided a target price of $80 on this stock.
The stock price of Viking Therapeutics Inc [VKTX] has been fluctuating between $18.92 and $81.86 over the past year. Currently, Wall Street analysts expect the stock to reach $98 within the next 12 months. Viking Therapeutics Inc [NASDAQ: VKTX] shares were valued at $23.94 at the most recent close of the market. An investor can expect a potential return of 309.36% based on the average VKTX price forecast.
Analyzing the VKTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.12 and Total Capital is -0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.07 points at the first support level, and at 20.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.96, and for the 2nd resistance point, it is at 25.99.
Ratios To Look Out For
It’s worth pointing out that Viking Therapeutics Inc [NASDAQ:VKTX]’s Current Ratio is 33.09. On the other hand, the Quick Ratio is 33.09, and the Cash Ratio is 0.97.
Transactions by insiders
Recent insider trading involved Rouan Sarah Kathryn, Director, that happened on Mar 31 ’25 when 1240.0 shares were purchased. President & CEO, Lian Brian completed a deal on Jan 06 ’25 to sell 0.19 million shares. Meanwhile, Chief Operating Officer Mancini Marianna sold 54215.0 shares on Jan 06 ’25.
